Description
Semi-quantitative IHC test for PD-L1 (B7-H1, CD274) expression, used to guide treatment with immune checkpoint inhibitors in various cancers, particularly those with high PD-L1 expression.
In Stock
฿38,650.00
Also Known As | PD-L1 Semi-Quantitative IHC, CD274 Staining, B7-H1 Immunohistochemistry |
---|---|
Specimen | Formalin-fixed, paraffin-embedded tissue block; or 3 unstained glass, “positively charged" slides with 4- microns formalin-fixed, paraffin- embedded tissue |
Turnaround Time | 23 days |
Test Code | MD-NLG664 |
Test Type | Special |
Related Tests | PB PDL-1 IHC, Tumor Mutational Burden |
Semi-quantitative IHC test for PD-L1 (B7-H1, CD274) expression, used to guide treatment with immune checkpoint inhibitors in various cancers, particularly those with high PD-L1 expression.
Guest users can Add to Cart and Checkout on the next page.
Add and Checkout feature currently supports logged-in users only.
Semi-quantitative IHC test for PD-L1 (B7-H1, CD274) expression, used to guide treatment with immune checkpoint inhibitors in various cancers, particularly those with high PD-L1 expression.
Also Known As | PD-L1 Semi-Quantitative IHC, CD274 Staining, B7-H1 Immunohistochemistry |
---|---|
Specimen | Formalin-fixed, paraffin-embedded tissue block; or 3 unstained glass, “positively charged" slides with 4- microns formalin-fixed, paraffin- embedded tissue |
Turnaround Time | 23 days |
Test Code | MD-NLG664 |
Test Type | Special |
Related Tests | PB PDL-1 IHC, Tumor Mutational Burden |
Find quality services, specialists, procedures and more from the comfort of your home. All you need to do is enter a keyword or phrase describing what you are looking for.
DOWNLOAD MEDEX ONE APP
MedEx decentralizes the care continuum as a one-stop care navigation concierge, transforming the care delivery model through its Pan-Asia provider aggregation platform, primary satellite clinics, telemedicine services, and at-home health care solutions.
MedEx connects you with world-class health care providers across borders, makes medical travel simple, low-cost and transparent and offers premium primary care.
© 2020-24 MedEx Ventures Co., Ltd.